The IQ Candriam Healthy Hearts Index is a global modified market-cap weighted index that consists of the top-rated companies making a positive contribution to global health-related goals, including by providing solutions for monitoring and curing heart diseases and helping people adopt a healthy lifestyle that limits cardiovascular risks.
Mutual Fund to ETF Converter Tool
We’re sorry, there are no active ETFs associated with this index.
Sort By:
ETF Database staff has allocated each ETF in the ETF database, as well as each index, to a single ‘best-fit’ ETF Database Category. Other ETFs in the Health & Biotech Equities ETF Database Category are presented in the following table.
* Assets in thousands of U.S. Dollars.
Historical return data for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Fund flow information for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Expense information for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Dividend information for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Holdings data for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Tax Rate data for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Technical information for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Links to analysis of other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
Links to a proprietary ETF Database rating for other ETFs in the Health & Biotech Equities ETF Database Category is presented in the following table.
| Symbol | ETF Name | Asset Class | Total Assets* | YTD | Avg Volume | Previous Closing Price | 1-Day Change | Overall Rating | 1 Week | 1 Month | 1 Year | 3 Year | 5 Year | YTD FF | 1 Week FF | 4 Week FF | 1 Year FF | 3 Year FF | 5 Year FF | ETF Database | Inception | ER | Commission Free | Annual Dividend Rate | Dividend Date | Dividend | Annual Dividend Yield % | P/E Ratio | Beta | # of Holdings | % In Top 10 | Complete | ST Cap Gain Rate | LT Cap Gain Rate | Tax Form | Lower Bollinger | Upper Bollinger | Support 1 | Resistance 1 | RSI | Advanced | Fact Sheet | ETF Holdings | Chart | ETF Home Page | Head-To-Head | Liquidity Rating | Expenses Rating | Returns Rating | Volatility Rating | Dividend Rating | Concentration Rating |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| XLV | Health Care Select Sector SPDR Fund | Equity | $38,879,700 | 7.0% | 6,732,682.0 | $144.28 | -0.57% | -2.1% | -2.4% | 11.2% | 5.1% | 9.6% | Health & Biotech Equities | 1998-12-16 | 0.09% | N/A | $2.27 | 2024-09-23 | $0.58 | 1.57% | 16.7 | 0.70 | 63 | 56.6% | View | 40% | 20% | 1099 | $140.73 | $150.43 | $143.77 | $145.13 | 40.58 | View | View | View | View | View | View | A | A | |||||||||||
| VHT | Vanguard Health Care ETF | Equity | $17,384,600 | 7.6% | 182,794.0 | $266.95 | -0.34% | -1.9% | -2.1% | 12.6% | 4.0% | 8.9% | Health & Biotech Equities | 2004-01-26 | 0.10% | Vanguard | $3.85 | 2024-09-27 | $1.17 | 1.44% | 22.0 | 0.73 | 410 | 48.0% | View | 40% | 20% | 1099 | $258.94 | $278.35 | $266.19 | $268.23 | 42.86 | View | View | View | View | View | View | A | A | |||||||||||
| IBB | iShares Biotechnology ETF | Equity | $6,842,400 | 4.2% | 1,226,651.0 | $141.30 | 0.96% | -0.2% | -2.6% | 13.6% | -1.3% | 3.8% | Health & Biotech Equities | 2001-02-05 | 0.45% | N/A | $0.45 | 2024-09-25 | $0.20 | 0.32% | 15.7 | 0.84 | 210 | 47.1% | View | 40% | 20% | 1099 | $131.33 | $148.97 | $140.28 | $142.27 | 49.67 | View | View | View | View | View | View | A | B | |||||||||||
| XBI | SPDR S&P Biotech ETF | Equity | $6,839,550 | 11.2% | 8,357,139.0 | $99.14 | 1.86% | -0.5% | -1.5% | 23.3% | -3.2% | 1.3% | Health & Biotech Equities | 2006-01-31 | 0.35% | N/A | $0.14 | 2024-09-23 | $0.02 | 0.15% | 17.9 | 0.97 | 144 | 27.4% | View | 40% | 20% | 1099 | $91.13 | $104.58 | $97.94 | $100.04 | 52.17 | View | View | View | View | View | View | A+ | A | |||||||||||
| IHI | iShares U.S. Medical Devices ETF | Equity | $4,641,920 | 11.8% | 561,694.0 | $60.17 | 0.00% | -1.5% | 1.1% | 19.4% | -0.5% | 7.2% | Health & Biotech Equities | 2006-05-01 | 0.40% | N/A | $0.26 | 2024-09-25 | $0.08 | 0.43% | 34.2 | 0.85 | 49 | 73.9% | View | 40% | 20% | 1099 | $59.49 | $61.21 | N/A | N/A | 52.71 | View | View | View | View | View | View | A | A- | |||||||||||
| IXJ | iShares Global Healthcare ETF | Equity | $3,943,380 | 5.9% | 141,602.0 | $91.19 | -0.24% | -1.4% | -2.6% | 10.5% | 3.9% | 7.7% | Health & Biotech Equities | 2001-11-13 | 0.41% | N/A | $1.23 | 2024-06-11 | $0.67 | 1.34% | 21.8 | 0.67 | 114 | 43.9% | View | 40% | 20% | 1099 | $88.43 | $94.42 | $90.93 | $91.57 | 40.12 | View | View | View | View | View | View | A | B+ | |||||||||||
| IYH | iShares U.S. Healthcare ETF | Equity | $3,227,400 | 7.5% | 255,172.0 | $61.01 | -0.36% | -1.8% | -2.4% | 11.7% | 4.2% | 9.0% | Health & Biotech Equities | 2000-06-12 | 0.39% | N/A | $0.71 | 2024-09-25 | $0.23 | 1.15% | 21.7 | 0.71 | 108 | 54.5% | View | 40% | 20% | 1099 | $59.25 | $63.55 | $60.81 | $61.31 | 41.67 | View | View | View | View | View | View | B+ | B+ | |||||||||||
| FHLC | Fidelity MSCI Health Care Index ETF | Equity | $2,785,660 | 7.6% | 107,705.0 | $68.87 | -0.29% | -1.9% | -2.0% | 12.5% | 4.0% | 8.9% | Health & Biotech Equities | 2013-10-21 | 0.08% | Fidelity | $0.95 | 2024-09-20 | $0.25 | 1.38% | 21.8 | 0.72 | 364 | 49.2% | View | 40% | 20% | 1099 | $66.78 | $71.76 | $68.65 | $69.18 | 42.99 | View | View | View | View | View | View | A | A+ | |||||||||||
| ARKG | ARK Genomic Revolution ETF | Equity | $1,175,490 | -19.4% | 2,224,774.0 | $26.43 | 4.88% | 1.7% | 6.7% | -7.9% | -23.1% | -3.5% | Health & Biotech Equities | 2014-10-31 | 0.75% | N/A | $0.00 | 2021-12-29 | $0.38 | 0.00% | N/A | 1.50 | 37 | 57.7% | View | 40% | 20% | 1099 | $22.35 | $27.63 | $25.71 | $26.94 | 56.38 | View | View | View | View | View | View | A | C+ | |||||||||||
| FBT | First Trust NYSE Arca Biotechnology Index Fund | Equity | $1,165,670 | 11.0% | 30,440.0 | $175.42 | 0.96% | 0.8% | -0.7% | 20.4% | 5.1% | 3.7% | Health & Biotech Equities | 2006-06-19 | 0.56% | N/A | $0.00 | 2021-12-30 | $2.21 | 0.00% | 17.6 | 0.79 | 31 | 38.9% | View | 40% | 20% | 1099 | $161.08 | $181.78 | $174.33 | $176.61 | 56.29 | View | View | View | View | View | View | B+ | B- | |||||||||||
| Click Here to Join to ETF Database Pro for 14 Days Free, Export This Data & So Much More | ||||||||||||||||||||||||||||||||||||||||||||||||||||
A long-running debate in asset allocation circles is how much of a portfolio an investor should...
In a digital age where information moves in milliseconds and millions of participants can transact...